INCREASE OF RAT PULMONARY MICROVASCULAR PERMEABILITY TO ALBUMIN BY RECOMBINANT INTERLEUKIN-2
- 1 July 1987
- journal article
- research article
- Vol. 47 (13) , 3528-3532
Abstract
Immunotherapy with the lymphokine interleukin-2 (IL-2), with or without lymphokine activated killer (LAK) cells, offers a new approach to the treatment of solid tumors. Unfortunately, most patients receiving IL-2 and LAK cells develop a "third space syndrome" from a presumed generalized increase of vascular permeability. We have investigated the role of IL-2 on lung fluid balance, by measuring changes in lung water and albumin intake. Rats were injected with IL-2 500,000 U i.p. three times a day for 1 to 4 days. At the completion of the injections, lungs were isolated and perfused, and total lung water (TLW) and 125I-albumin uptake were measured. After 1 day of injections, TLW increased from 4.90 .+-. 0.14 to 5.57 .+-. 0.34 dry lung and albumin uptake nearly doubled from 0.47 .+-. 0.08 to 0.91 .+-. 0.28 cm3/s/g dry lung .times. 10-3. Longer injection periods increased both TLW and albumin uptake further. After 2 days, TLW and albumin uptake were also significantly increased by 160,000 U i.p. three times a day, but not by 40,000 or 10,000 U. To eliminate possible contributions to increased permeability by (a) LAK cells generated in vivo, or (b) circulating leukocytes, we isolated lungs from normal rats and perfused them for 5 min with a cell-free perfusate containing IL-2 (2, 10, or 5 .times. 10-3 U/ml) excipient or 0.9% NaCl placebo. TLW was similar in all groups, but albumin uptake was significantly increased by 10,000 and 50,000 U/ml (0.94 .+-. 0.15 and 0.82 .+-. 0.16 cm3/s/g dry lung .times. 10-3, respectively), but not by 2,000 U/ml. We conclude that lung microvascular albumin permeability is increased following administration of IL-2 in vivo and in vitro. We suggest that LAK cells are not required for the initiation of increased permeability and that IL-2 may have some direct effect on the pulmonary microvasculature.This publication has 13 references indexed in Scilit:
- Systemic administration of recombinant interleukin 2 stimulates in vivo lymphoid cell proliferation in tissues.The Journal of Immunology, 1985
- The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo.The Journal of Immunology, 1985
- Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.The Journal of Experimental Medicine, 1985
- Interferon-gamma enhances induction of lymphotoxin in recombinant interleukin 2-stimulated peripheral blood mononuclear cells.The Journal of Immunology, 1985
- SUCCESSFUL IMMUNOTHERAPY OF MURINE EXPERIMENTAL HEPATIC METASTASES WITH LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-21985
- TOXICITY OF RECOMBINANT HUMAN INTERLEUKIN-2 IN RATS FOLLOWING INTRAVENOUS-INFUSION1985
- Biological Activity of Recombinant Human Interleukin-2 Produced in Escherichia coliScience, 1984
- Endothelial albumin permeability measured with a new technique in perfused rabbit lungAmerican Journal of Physiology-Heart and Circulatory Physiology, 1983
- Interleukin 2 induces gamma-interferon production: participation of macrophages and NK-like cells.The Journal of Immunology, 1983
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982